Trial Profile
The clinical effects of peramivir on influenza virus infections in infants (age; over 28 days old, under 4 years old): an open-label,non-randomized, multi-centre study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2013
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza A virus H1N1 subtype; Influenza A virus H3N2 subtype; Influenza B virus infections
- Focus Therapeutic Use
- 23 Aug 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 20 Jan 2013 Planned number of patients changed from 24 to 48 as reported by University Hospital Medical Information Network - Japan.
- 20 Jan 2013 Status changed from completed to recruiting as reported by University Hospital Medical Information Network - Japan.